Quantum Cyber earnings matched, revenue topped estimates

Quantum Cyber (QUCY) reported Q3 EPS of -$0.08, matching estimates, with revenue of $970K, exceeding the $950K consensus. The stock is down 61.74% over 3 months and 61.34% over 12 months. InvestingPro rates its financial health as 'weak performance'.

Original reporting
Published Nov 12, 2026, 11:50 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 13, 2026, 12:00 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$QUCY
Bearish
high confidence
Mentioned
$QUCY
Relevance
6/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$QUCYBearishMed
01

Why it matters

The earnings release confirms weak profitability and a weak health rating, likely prompting short‑term downside.

02

Market read

Earnings release for a micro‑cap with negative EPS; limited broader market relevance.

03

What to watch

Potential upcoming contracts or strategic partnerships not disclosed in this brief could offset the weak earnings.

Relevance 6/10Novelty 7/10Timing: after-hours

Background

Quantum Cyber (NASDAQ: QUCY) is a micro‑cap cybersecurity firm that posted its Q3 results.

Company-level read

Ticker impact

$QUCYBearishHigh confidence
Context

QCY reported Q3 earnings with EPS of -$0.08 and revenue of $970K, matching estimates.

Expected impact

likely pressure as the market prices in weak earnings and weak health score

Evidence & confidence

Negative EPS and a 'weak performance' health rating for a micro‑cap typically trigger sell‑offs.

Market effects

Minimal impact on the broader cybersecurity sector due to the company's small size.

Negligible effect on US markets overall.

Low

Counterpoint

If the stock is already heavily discounted, the earnings match may be a floor rather than a trigger for further decline.

Key entities

  • Quantum Cyber

    NASDAQ‑listed cybersecurity firm

Related articles

$QUCYMed

Quantum Cyber Reports First Revenue of ~$1.0 Million and Announces $8.0 Million Funding Commitment From Chief Executive Officer David Lazar Third Quarter…

Quantum Cyber N.V. (QUCY) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Quantum Cyber Reports First Revenue of ~$1.0 Million and Announces $8.0 Million Funding Commitment From Chief Executive Officer David Lazar Third Quarter 2026 Form 10-Q Highlights: ● Four customers each accounting for 10% or more of quarterly revenue, with no single

$QUCYMed

Quantum Cyber N.V. (QUCY) Appoints Maj. Gen. Rosende to Board

Quantum Cyber N.V. (QUCY) added Maj. Gen. (Ret.) Alberto C. Rosende to its board to oversee its Bridgeport, CT facility and supply chain for autonomous drones. The move supports the company's focus on domestic, vertically integrated manufacturing to meet U.S. demand, which could become a revenue catalyst if milestones are met.

$QUCYLow

Quantum Cyber N.V. (QUCY): Completion of Acquisition or Disposition of Assets

Quantum Cyber N.V. (QUCY) filed an SEC Form 8-K — Completion of Acquisition or Disposition of Assets. false 0001874252 00-0000000 0001874252 2026-07-15 2026-07-15 0001874252 dei:FormerAddressMember 2026-07-15 2026-07-15 iso4217:USD xbrli:shares iso4217:USD xbrli:shares UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Sect

$SUNEMed

SUNATION ENERGY ANNOUNCES THIRD QUARTER 2026 RESULTS; REPORTS SEQUENTIAL REVENUE AND GROSS MARGIN IMPROVEMENT AND PROVIDES SUNIVA MERGER UPDATE

SUNation Energy, Inc. (SUNE) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 SUNATION ENERGY ANNOUNCES THIRD QUARTER 2026 RESULTS; REPORTS SEQUENTIAL REVENUE AND GROSS MARGIN IMPROVEMENT AND PROVIDES SUNIVA MERGER UPDATE Third-quarter revenue of $11.2 million increased from $8.2 million in the second quarter; year-over-year results continued